HARVARD MANAGEMENT CO INC Q1 2022 holdings

$991 Million is the total value of HARVARD MANAGEMENT CO INC's 44 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 13.0% .

 Value Shares↓ Weighting
FB BuyMETA PLATFORMS INCcl a$273,729
+118.7%
1,231,019
+230.8%
27.63%
+135.2%
GOOGL BuyALPHABET INCcap stk cl a$242,219
+37.0%
87,087
+42.7%
24.45%
+47.4%
SGMS  SCIENTIFIC GAMES CORP$157,366
-12.1%
2,678,5710.0%15.88%
-5.5%
ABCL  ABCELLERA BIOLOGICS INC$40,025
-31.8%
4,105,0950.0%4.04%
-26.7%
 EQRX INC$21,733
-39.4%
5,262,1610.0%2.19%
-34.9%
PCT BuyPURECYCLE TECHNOLOGIES INC$19,985
+95.2%
2,498,170
+133.6%
2.02%
+109.9%
RVMD  REVOLUTION MEDICINES INC$17,101
+1.3%
670,3820.0%1.73%
+9.0%
RLAY  RELAY THERAPEUTICS INC$16,196
-2.5%
541,1240.0%1.64%
+4.8%
TXG  10X GENOMICS INC$14,160
-48.9%
186,1430.0%1.43%
-45.1%
BuyGRAB HOLDINGS LIMITEDclass a ord$12,897
-9.6%
3,684,960
+84.2%
1.30%
-2.7%
RXRX  RECURSION PHARMACEUTICALS INcl a$10,806
-58.2%
1,509,2540.0%1.09%
-55.0%
 MELI KASZEK PIONEER CORPclass a ord$10,280
-11.1%
1,000,0000.0%1.04%
-4.3%
FULC  FULCRUM THERAPEUTICS INC$9,713
+33.7%
410,7140.0%0.98%
+43.7%
 ROCKET LAB USA INC$8,050
-34.4%
1,000,0000.0%0.81%
-29.5%
AFRM  AFFIRM HLDGS INC$8,032
-54.0%
173,5600.0%0.81%
-50.5%
MU  MICRON TECHNOLOGY INC$7,998
-16.4%
102,6840.0%0.81%
-10.1%
PRAX  PRAXIS PRECISION MEDICINES I$7,949
-48.2%
778,5170.0%0.80%
-44.3%
 TENAYA THERAPEUTICS INC$7,931
-37.8%
673,2700.0%0.80%
-33.1%
INTC  INTEL CORP$7,474
-3.8%
150,8060.0%0.75%
+3.4%
NVDA  NVIDIA CORPORATION$7,180
-7.2%
26,3150.0%0.72%
-0.1%
ADI  ANALOG DEVICES INC$6,894
-6.0%
41,7390.0%0.70%
+1.0%
LRCX  LAM RESEARCH CORP$6,731
-25.2%
12,5210.0%0.68%
-19.6%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$6,719
-13.3%
64,4430.0%0.68%
-6.9%
AMAT  APPLIED MATLS INC$6,663
-16.2%
50,5530.0%0.67%
-9.9%
AMD  ADVANCED MICRO DEVICES INC$5,971
-24.0%
54,6100.0%0.60%
-18.3%
QRVO  QORVO INC$5,828
-20.7%
46,9630.0%0.59%
-14.7%
KNTE  KINNATE BIOPHARMA INC$5,607
-36.5%
498,0010.0%0.57%
-31.6%
 TANGO THERAPEUTICS INC$5,370
-30.7%
708,3850.0%0.54%
-25.4%
CFLT  CONFLUENT INC$5,346
-46.2%
130,3830.0%0.54%
-42.1%
NRIX  NURIX THERAPEUTICS INC$4,410
-51.6%
314,7620.0%0.44%
-48.0%
PLRX  PLIANT THERAPEUTICS INC$3,942
-48.1%
562,3790.0%0.40%
-44.2%
SANA  SANA BIOTECHNOLOGY INC$3,872
-46.6%
468,7490.0%0.39%
-42.6%
GBIO  GENERATION BIO CO$3,746
+3.7%
510,3540.0%0.38%
+11.5%
 XILIO THERAPEUTICS INC$2,942
-55.8%
416,0590.0%0.30%
-52.5%
 PARDES BIOSCIENCES INC$2,888
-55.9%
400,0000.0%0.29%
-52.5%
 SURROZEN INC$2,489
-53.3%
826,8520.0%0.25%
-49.8%
PACB  PACIFIC BIOSCIENCES CALIF IN$2,085
-55.5%
229,1440.0%0.21%
-52.3%
PCTTW NewPURECYCLE TECHNOLOGIES INC*w exp 03/17/202$2,050714,285
+100.0%
0.21%
NewVIGIL NEUROSCIENCE INC$2,035289,460
+100.0%
0.20%
DYN  DYNE THERAPEUTICS INC$1,034
-18.9%
107,2520.0%0.10%
-13.3%
DBTX  DECIBEL THERAPEUTICS INC$1,000
-34.6%
328,7980.0%0.10%
-29.9%
MGTA  MAGENTA THERAPEUTICS INC$965
-34.5%
332,6100.0%0.10%
-29.7%
MCRB  SERES THERAPEUTICS INC$939
-14.5%
131,8470.0%0.10%
-7.8%
GMTX  GEMINI THERAPEUTICS INC$348
-52.2%
250,0000.0%0.04%
-48.5%
ExitSURROZEN INC*w exp 08/01/203$0-108,333
-100.0%
-0.01%
DADA ExitDADA NEXUS LTDads$0-40,338
-100.0%
-0.05%
ASML ExitASML HOLDING N V$0-9,034
-100.0%
-0.68%
RPRX ExitROYALTY PHARMA PLC$0-3,464,990
-100.0%
-12.96%

These EDGAR filings were analyzed to create this holdings report:

The EDGAR filing(s) were signed by:

  • Kathryn I. Murtagh — Managing Director - Chief Compliance Officer

Compare quarterly holdings

Export HARVARD MANAGEMENT CO INC's holdings

EDGAR filings